Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma
Open Access
- 1 January 2018
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 9 (12) , 2132-2139
Abstract
Background: Preoperative neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are associated with poor prognosis in soft tissue sarcoma (STS). The aim of the present study is to determine whether the combination of NLR and PLR (CNP) can better predict patient survival after resection for STS.Keywords
This publication has 38 references indexed in Scilit:
- Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinomaOncoTargets and Therapy, 2013
- Platelets, coagulation and fibrinolysis in breast cancer progressionBreast Cancer Research, 2013
- Optimization of the systemic inflammation‐based Glasgow Prognostic ScoreCancer, 2013
- Tumor-Associated Neutrophils: New Targets for Cancer TherapyCancer Research, 2011
- The platelet contribution to cancer progressionJournal of Thrombosis and Haemostasis, 2011
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patientsBlood, 2009
- Cancer-related inflammationNature, 2008
- Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapyCancer, 2003